Try our Advanced Search for more refined results
Anchen Pharmaceuticals Inc.
-
Utility | Filed: January 03, 2024 | Entered: January 03, 2024 Takeda Pharmaceutical Co., Ltd. et al v. Anchen Pharmaceuticals, Inc.
Patent | California Northern
Remark
Remark: Trial Exhibits disposed of in accordance with Local Rule 79-4(c). (msr, COURT STAFF) (Filed on 1/3/2024)
-
Other Event | Filed: September 20, 2023 | Entered: September 20, 2023 Takeda Pharmaceutical Co., Ltd. et al v. Anchen Pharmaceuticals, Inc.
Patent | California Northern
Clerk's Notice
CLERK'S NOTICE re Exhibits. The deadline for retrieving trial exhibits in the custody of the Clerks Office has passed. Counsel must indicate their intention to retrieve or abandon trial exhibits by filing a Notice within 10 days. If timely notice is not received, the exhibits will be disposed of according to the Courts document destruction policies.
(This is a text-only entry generated by the court. There is no document associated with this entry.) (wsn, COURT STAFF) (Filed on 9/20/2023) -
Utility | Filed: February 17, 2023 | Entered: February 22, 2023 In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Terminate Case - Misc. or MD
CASE CLOSED per entry of the Consent Judgment at D.I. 694 . There are no remaining civil actions part of this MDL that are open at this time. (nms)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login